The prime objective of SynbiCITE is to accelerate and promote the commercial exploitation of synthetic biology research and technology. The London DNA Foundry provides a suite of state-of-the-art robotic equipment enabling automated end-to-end design, construction and validation of large gene constructs. It is designed to bridge the gap between academia and industry, accelerating developments in engineering biology technologies and allowing SynbiCITE’s partners to prototype new biologically-based chemicals, drugs and materials.
We ensure that the work of our academic and industrial partners gives innovative solutions to important societal challenges and does so ethically, legally and with the safety of society and the environment as a priority. For more information on our commitment to responsible innovation please visit www.synbicite.com.